NCT04206371View on ClinicalTrials.gov

Defibrillation Testing During Implantable Cardioverter Defibrillator (ICD) Replacement

NACompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

February 3, 2020

Primary Completion Date

January 19, 2022

Study Completion Date

June 27, 2023

Conditions
Implantable Cardioverter-Defibrillators
Interventions
DIAGNOSTIC_TEST

Defibrillator threshold testing

Under general or local anesthesia. Induction of Ventricular Fibrillation or R-wave synchronized shock

Trial Locations (7)

14000

CHU de Caen, Caen

31400

CHU de Toulouse-Hôpital Rangueil, Toulouse

37170

Hôpital Trousseau, Chambray-lès-Tours

44277

Hôpital Privé du Confluent, Nantes

54500

Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu-CHU de Nancy-Hôpitaux de Brabois, Vandœuvre-lès-Nancy

84902

Centre Hospitalier Henri Duffaut, Avignon

92200

CMC Ambroise Paré, Neuilly-sur-Seine

All Listed Sponsors
lead

CMC Ambroise Paré

OTHER

NCT04206371 - Defibrillation Testing During Implantable Cardioverter Defibrillator (ICD) Replacement | Biotech Hunter | Biotech Hunter